Equities

Sharps Technology Inc

STSS:NAQ

Sharps Technology Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.29
  • Today's Change0.000 / 0.14%
  • Shares traded1.50m
  • 1 Year change-65.46%
  • Beta--
Data delayed at least 15 minutes, as of Jul 29 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

  • Revenue in USD (TTM)0.00
  • Net income in USD-8.71m
  • Incorporated2017
  • Employees3.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
STSS:NAQ since
announced
Transaction
value
Nephron Pharmaceuticals Corp-InjectEZ facilityAnnounced26 Sep 202326 Sep 2023Announced-55.38%--
Data delayed at least 15 minutes, as of Jul 29 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Applied DNA Sciences Inc5.52m-12.50m3.70m53.00------0.6698-17.13-17.137.67-0.05580.389310.384.64104,110.80-87.15-88.57-111.09-121.9133.9844.35-223.89-113.261.54-------26.4327.92-18.73--33.80--
AccuStem Sciences Inc0.00-1.74m3.90m3.00---------0.1537-0.15370.00-0.23090.00----0.00-1,168.46--------------------------45.26------
SINTX Technologies Inc2.78m-8.88m3.94m43.00--0.0138--1.42-389.94-389.9474.21383.240.1381.625.8464,534.88-44.03-45.71-57.11-57.3667.9658.47-318.99-681.801.67--0.0229--68.2994.2449.75--54.10--
Arch Therapeutics Inc130.55k-8.43m4.00m8.00------30.64-3.68-3.680.0425-2.450.08330.0637--16,318.75-538.25-188.28---804.6333.37---6,458.14-26,945.920.0164-1.27----383.83---32.35---21.76--
Venus Concept Inc73.30m-37.39m4.07m304.00------0.0555-6.69-6.6913.12-3.540.74091.062.21241,125.00-37.61-32.71-56.83-44.0168.3768.16-50.77-48.501.35-3.441.40---23.2628.3114.76---35.08--
Encision Inc6.59m-691.78k4.27m22.00--2.34--0.6489-0.0588-0.05880.55950.1541.662.097.27299,357.70-17.41-3.03-24.73-4.1347.6251.25-10.50-1.890.8393-10.270.1272---10.38-5.64-113.55---9.54--
Dror Ortho-Design Inc0.00-4.83m4.46m4.00--1.87-----0.0115-0.01150.000.00480.00-------357.10-140.50-595.21---------118,188.00----0.00-------1,896.02------
Sharps Technology Inc0.00-8.71m4.54m3.00--0.6615-----0.6204-0.62040.000.43780.00-------74.67---95.84----------0.492--0.00-------112.12------
Reflect Scientific Inc1.27m-343.17k4.67m7.00--2.51--3.68-0.004-0.0040.01480.02170.51290.61845.72181,111.40-13.8811.10-16.4313.2156.0662.48-27.0710.002.21--0.00---47.09-6.99-613.46------
ReShape Lifesciences Inc8.34m-10.92m4.73m31.00--1.04--0.5674-2.30-2.300.73190.19330.67810.81784.52268,871.00-88.83-136.06-162.20-194.3265.8556.30-130.99-408.361.26--0.00---22.79-0.947475.36---49.29--
Nu-Med Plus Inc0.00-119.16k4.75m2.00---------0.0014-0.00140.00-0.0020.00----0.00-350.01-447.69---------------22.74--------3.56------
Aethlon Medical, Inc.0.00-12.21m5.11m14.00--0.1676-----4.87-4.870.002.190.00----0.00-94.80-76.25-108.90-85.78-------2,246.87----0.00---100.00---1.43------
Caduceus Software Systems Corp0.00-117.60k5.35m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
ADM Tronics Unlimited Inc2.97m-877.23k5.35m7.00--7.73--1.81-0.013-0.0130.04390.01021.134.897.04---33.56-15.22-58.66-22.0937.6541.15-29.58-18.580.8015-316.560.4233---19.35-0.3572-810.74------
Sonendo Inc40.19m-57.74m5.39m216.00--0.2197--0.1341-0.6125-0.55520.4260.34820.44482.077.58186,055.60-63.91---78.82--27.64---143.67--2.14-10.830.4695--5.30---6.78------
Predictive Oncology Inc1.96m-14.78m5.66m34.00--1.38--2.89-3.66-3.660.48530.99770.10991.714.9557,642.65-82.89-91.80-108.54-126.2964.1864.64-754.19-1,419.991.35--0.0093--18.244.7545.67--5.44--
Data as of Jul 29 2024. Currency figures normalised to Sharps Technology Inc's reporting currency: US Dollar USD

Institutional shareholders

10.81%Per cent of shares held by top holders
HolderShares% Held
Empery Asset Management LPas of 31 Dec 20231.24m5.35%
Walleye Capital LLCas of 31 Mar 2024886.51k3.84%
Hightower Advisors LLCas of 31 Mar 2024120.80k0.52%
ORG Partners LLCas of 30 Jun 2024100.05k0.43%
Compass Ion Advisors LLCas of 30 Jun 202457.14k0.25%
Geode Capital Management LLCas of 31 Mar 202441.18k0.18%
XTX Markets LLCas of 31 Mar 202426.51k0.12%
SSgA Funds Management, Inc.as of 31 Mar 202421.06k0.09%
Tower Research Capital LLCas of 31 Mar 20246.47k0.03%
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 202491.000.00%
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.